Causality Classification in Pharmacovigilance: Explained
A simplified guide to causality assessment in pharmacovigilance, covering WHO-UMC classifications and key criteria for evaluating adverse drug reactions.
Greetings and welcome to our ICSR community! Here, we share valuable insights on the nuances of ICSR case processing, no matter how small, to help you process cases effectively. We believe in sharing knowledge and information that we have to help our community grow.
A simplified guide to causality assessment in pharmacovigilance, covering WHO-UMC classifications and key criteria for evaluating adverse drug reactions.
Causality assessment is one of the most critical and challenging tasks in pharmacovigilance. It requires more than simply linking an adverse event to a drug.
Assessing ADR-AE (Adverse Drug Reactions and Adverse Events) are more than regulatory terminology—so it is necessary to report rightly. so here we explore.
This article explores the practical considerations, & common challenges involved in causality assessment, highlighting why it remains one of the toughest tasks.
Concomitant medications are a constant reality in modern clinical practice and play a critical role in pharmacovigilance safety assessment. Let’s dive in.
This blog features: Introduction Concomitant drugs are one of the most frequently coded elements in case processing, alongside…
Drug indications might seem like a simple detail, but in PV case processing they can quickly become tricky. Let’s discuss in deeper.
This blog features: Introduction This blog provides a clear and concise overview of the Qualified Person for Pharmacovigilance…
Copyright © Drugvigil. All Rights Reserved.